Kahn Brothers Group recent buys & sells (2020 Q4)
Thomas Graham, Alan, Irving Kahns
Kahn Brothers Group Portfolio Changes
Purchase & sale details
- Portfolio value:
- $573.28M (+$46M)
- Previous value:
- $527.50M
- # of changes:
- 31
- New positions:
- 1
- Reported for:
- 31 Dec 2020 (Q4)
- Latest filing date:
- 11 Feb 2021
Kahn Brothers Group has disclosed a total of 31 changes to the portfolio in the (2020 Q4) SEC report(s): increased the number of shares of 3, bought 1 totally new, decreased the number of shares of 26 and completely sold out 1 position(s).
What did Kahn Brothers Group invest in during 2020 Q4?
In the 2020 Q4 report(s) the following changes have been made to the top investments: (MRK) Merck & Company Inc (reduced shares -8.93%), (BMY) Bristol-Myers Squibb Company (reduced shares -7.66%), (C) Citigroup Inc (reduced shares -4.04%), (AGO) ASSURED GUARANTY LTD (reduced shares -8.26%) and (GSK) GlaxoSmithKline PLC ADR (reduced shares -8.87%).
31 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Viatris Inc
|
new
|
$18.74
|
-1.84%($18.40)
|
0.31%
|
2020 Q4
|
~0.25 years
|
||||
|
|
Hologic Inc
|
+7.77%
|
$72.83
|
|
0.58%
|
2013 Q2*
|
> 7 years
|
||||
|
|
MBIA Inc
|
+5.58%
|
$6.58
|
-33.43%($4.38)
|
5.63%
|
2013 Q2*
|
> 7 years
|
||||
|
|
Trinity Place Holdings Inc
|
+2.00%
|
$1.25
|
-97.80%($0.03)
|
0.29%
|
2013 Q2*
|
> 7 years
|
||||
|
|
Novartis AG ADR
|
-1.32%
|
$94.43
|
+60.06%($151.14)
|
0.37%
|
2013 Q2*
|
> 7 years
|
||||
|
|
Pfizer Inc
|
-2.57%
|
$36.81
|
-19.68%($29.56)
|
4.33%
|
2013 Q2*
|
> 7 years
|
||||
|
|
Citigroup Inc
|
-4.04%
|
$61.66
|
+101.23%($124.08)
|
8.78%
|
2013 Q2*
|
> 7 years
|
||||
|
|
Bank of America Corp
|
-4.65%
|
$30.31
|
+70.22%($51.60)
|
0.07%
|
2013 Q2*
|
> 7 years
|
||||
|
|
PepsiCo Inc
|
-5.00%
|
$148.30
|
-11.64%($131.04)
|
0.05%
|
2019 Q3
|
~1.50 years
|
||||
|
|
Verizon Communications Inc
|
-5.28%
|
$58.75
|
-23.53%($44.92)
|
0.16%
|
2019 Q2
|
~1.75 years
|
||||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted. 2013 Q2 is the earliest period we have data for, so "2013 Q2*" means "2013 Q2 or earlier".